Using FibroScan to Assess for the Development of Liver Fibrosis in Patients With Arthritis on Methotrexate: A Single-center Experience.

Saman Darabian John P Wade Jason Kur Stefanie D Wade Eric C Sayre Maziar Badii

Published in: The Journal of rheumatology (2022)

No significant correlation between the cumulative MTX dosage and liver stiffness, even at high MTX doses, was observed. The analyses showed significant correlations between the FibroScan score and BMI. These findings were reassuring in that current rheumatology practice appears to be safe and effective in screening for liver fibrosis in patients on long-term low-dose MTX therapy.

Keyphrases

liver fibrosis
low dose
end stage renal disease
high dose
chronic kidney disease
ejection fraction
newly diagnosed
primary care
rheumatoid arthritis
prognostic factors
systemic lupus erythematosus
patient reported outcomes
physical activity
juvenile idiopathic arthritis
weight gain
disease activity